ExpreS2ion Biotech Holding AB (DE:5JD0)
FRANKFURT:5JD0
Germany Market
Holding DE:5JD0?
Track your performance easily

ExpreS2ion Biotech Holding AB (5JD0) Financial Statements

2 Followers

ExpreS2ion Biotech Holding AB Financial Overview

ExpreS2ion Biotech Holding AB's market cap is currently ―. The company's EPS TTM is €-2.631; its P/E ratio is -0.82; ExpreS2ion Biotech Holding AB is scheduled to report earnings on November 21, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenuekr 833.00Kkr 1.25Mkr 2.03Mkr 3.40Mkr 2.55M
Gross Profitkr -820.00Kkr 99.00Kkr 1.08Mkr 2.23Mkr 2.48M
EBITkr -31.45Mkr -26.41Mkr -14.64Mkr -15.98Mkr -9.82M
EBITDAkr -31.13Mkr -26.10Mkr -14.33Mkr -15.66Mkr -9.51M
Net Income Common Stockholderskr -30.70Mkr -25.54Mkr -13.84Mkr -14.32Mkr -9.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 149.56Mkr 167.72Mkr 124.68Mkr 138.88Mkr 142.00M
Total Assetskr 170.50Mkr 188.48Mkr 140.03Mkr 151.96Mkr 159.43M
Total Debtkr 1.81Mkr 1.83Mkr 1.86Mkr 1.92Mkr 1.96M
Net Debtkr -147.75Mkr -165.89Mkr -122.81Mkr -136.96Mkr -140.04M
Total Liabilitieskr 21.62Mkr 14.30Mkr 8.71Mkr 11.61Mkr 13.44M
Stockholders Equitykr 148.87Mkr 174.18Mkr 131.33Mkr 140.35Mkr 145.99M
Cash Flow-
Free Cash Flowkr -23.43Mkr -21.70Mkr -15.25Mkr -4.31Mkr -7.16M
Operating Cash Flowkr -23.34Mkr -21.61Mkr -15.23Mkr -4.31Mkr -6.96M
Investing Cash Flowkr 403.00Kkr 86.12Mkr 17.96Mkr -100.93Mkr -157.00K
Financing Cash Flowkr 2.35Mkr 60.27Mkr -603.00Kkr -503.00Kkr 40.33M
Currency in SEK

ExpreS2ion Biotech Holding AB Earnings and Revenue History

ExpreS2ion Biotech Holding AB Debt to Assets

ExpreS2ion Biotech Holding AB Cash Flow

ExpreS2ion Biotech Holding AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis